Quality of life measured by the St george's respiratory questionnaire and spirometry

European Respiratory Journal

Volumn 33, Issue 5, 2009, Pages 1025-1030

  Weatherall, M ^a   Marsh, S ^b   Shirtcliffe, P ^b   Williams, M ^b   Travers, J ^b   Beasley, R ^b  

^a UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

^b MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

Author keywords

Chronic obstructive pulmonary disease; Quality of life; Spirometry

Indexed keywords

BRONCHODILATING AGENT; SALBUTAMOL;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FUNCTION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPIROMETRY; STRUCTURED QUESTIONNAIRE;

ADULT; AGED; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPIROMETRY; VITAL CAPACITY;

EID: 66749134039     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00116808     Document Type: Article

References (24)

1. Global strategy for the diagnosis, management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2008. www.goldcopd. org Last updated: July 2008. Last accessed: February 2009.
2. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
3. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20: 1117-1122.
4. Mannino DM. Defining chronic obstructive pulmonary disease... and the elephant in the room. Eur Respir J 2007; 30: 189-190.
5. Hankinson J, Odencrantz J, Fedan K. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179-187.
6. Jones PW. St George's Respiratory Questionnaire: MCID. COPD 2005; 2: 75-79.
7. Maleki-Yasdi M, Lewczuk CK, Haddon JM, Choudry N, Ryan N. Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study. COPD 2007; 4: 313-320.
8. Ferrer M, Villasante C, Alonso J, et al. Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur Respir J 2002; 19: 405-413.
9. Shirtcliffe P, Weatherall M, Marsh S, et al. COPD prevalence in a random population survey: a matter of definition. Eur Respir J 2007; 30: 232-239.
10. Marsh S, Aldington S, Williams M, et al. Complete reference ranges for pulmonary function tests from a single New Zealand population. N Z Med J 2006; 119:U2281.
11. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152:1107-1136.
12. Jones P. Quality of life measurement for patients with diseases of the airways. Thorax 1991; 46: 676-682.
13. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85: Suppl. B, 25-31.
14. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self- complete measure of health status for chronic airflow limitation: the St George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
15. Koenker R. The R project for statistical computing. R package version 4/06/2007. www.r-project.org Date last updated: October 20, 2008. Last accessed: February 2009.
16. Freund RJ, Littell RC. Curve fitting. In: Freund RJ, Littell RC, eds. SAS System for Regression. 3rd Edn. Cary, SAS Institute, 2000; pp. 150-155.
17. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2008. www.ginasthma.org Date last updated: 2008. Date last accessed: February 2009.
18. Calverley P, Kerstjens H. Pro/con editorials: the GOLD classification has advanced understanding of COPD. Am J Respir Crit Care Med 2004; 170: 211-214.
19. Johannessen A, Lehmann S, Omenaas ER, Eide E, Bakke PS, Gulsvik A. Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006; 173: 1316-1325.
20. Mannino DM, Buist AS, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007; 62: 237-241.
21. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56: 880-887.
22. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350: 1005-1012.
23. Jones D. Long-acting inhaled bronchodilators for COPD - lack of logic continues. N Z Med J 2005; 118: U1669.
24. Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax 2008; 63:761-767.